No; however, that's all what we can rely on at the moment unfortunately. I did say I'll hold, and their other programs + LANI future prospect are what I am holding on for. Still, this sales figure greatly show that Lani did not pick up a lot of sales since last year (in fact, it dropped, get the hint?).
If they can't even get it up and running well, I am not sure what the hope is in the near future. I can only hope that in 5 years time when US approve it, we will finally get it going smoothly.
-The US stockpile market
Lani can only be sold in Japan, and don't get me started with the failure of Relenza. No matter what people said about tamipoo resistance, I reckon government will still stockpile it over relenza, the fact is right in front of you with all those figures. I do hope they will change to relenza, but hei, I won't put my hope up that high. If they do, it is a bonus!
-and the possibility of flu pandemics in the future
I surely hope this won't happen. As much as I like to make money, making money over lot of dead bodies are not the way I want to do it.
BTA has a future, without relying on flu pandemics. LANI can be used for normal flu as prevention, cure, etc. We don't need FLU pandemic.
- Forums
- ASX - By Stock
- BTA
- inavir royalties
inavir royalties, page-7
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online